Mesenchymal Stem Cell-derived Pleiotropic Factor in the Treatment of Donor Sites
- Conditions
- Evaluate the Safety and Effectiveness of Mesenchymal Stem Cell Conditioned Medium-derived Pleiotropic Factor in Treating Donor Sites
- Interventions
- Biological: mesenchymal stem cell conditioned medium-derived pleiotropic factor
- Registration Number
- NCT04234750
- Lead Sponsor
- Chinese PLA General Hospital
- Brief Summary
Skin grafting is a standard treatment for deep wounds, but care of the donor site after transplantation is very important. The means of accelerating wound healing can increase overall patient satisfaction. In recent years, cytokine therapy has been an important strategy to promote tissue repair.Mesenchymal stem cells (MSC) have been considered the star cells that promote tissue repair. It works mainly through paracrine. Many biological effectors, including IGF-1, vascular endothelial growth factor (VEGF), TGF-β1, and hepatocyte growth factor (HGF), have been found and reported in various MSC conditioned media (MSC-CM), And play a role in promoting tissue repair and regeneration. In here, we aim to explore the MSC-CM-derived pleiotropic factor in treating donor sites and further evaluate its safety and effectiveness
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 20
Mainly mild to moderate burns, III ° burn area is less than 20% (trauma factor is thermal burn); Thick-thickness skin (thickness 0.2-0.3mm), donor area and medium-thickness skin (thick 0.3-0.5mm) for the skin area study separately; Psychologically stable and able to complete the test process-
History of clotting disorders, uncontrolled diabetes; Drug abuse, excessive drinking, malignant or autoimmune diseases, chemotherapy and immunosuppressive therapy; Significant local infection or combined systemic infection; Patients with severe heart, lung, liver, kidney, blood system and mental and nervous system diseases; Women during pregnancy and lactation-
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description experimental group mesenchymal stem cell conditioned medium-derived pleiotropic factor mesenchymal stem cell conditioned medium-derived pleiotropic factor
- Primary Outcome Measures
Name Time Method wound healing rate 1 month Original wound area minus unhealed wound area divided by original wound area
- Secondary Outcome Measures
Name Time Method Vancouver score 6 months Score according to scale
Trial Locations
- Locations (1)
People's Liberation Army Central Air Force Hospital
🇨🇳Datong, Shanxi, China